Acquired shares of GMO Reserve Plus and became a consolidated company of GMO Payment Gateway
~Strengthening the management foundation through capital increase and strengthening group synergies, achieving stable business execution and accelerated growth~

GMO Payment Gateway, Inc. (GMO-PG) has reviewed its capital relationship with GMO Reserve Plus Co.,Ltd. (hereinafter referred to as "GMO Reserve Plus"), which it had previously developed through GMO Epsilon, Inc., and acquired shares in the company. As a result, GMO Reserve Plus will develop its business as a GMO-PG consolidated company from October 1, 2025 (Wednesday).
In addition, GMO Reserve Plus increased its capital and capital reserve to 846 million yen through a capital increase. As a result, we have established a stable business foundation and established a system to accelerate strategic investments in growth areas.

【Business Direction】
GMO Reserve Plus has been promoting medical DX by developing web consultations, online medical consultations, and cashless payment linkage with a SaaS-type reservation management system for medical institutions at its core.
In the future, we will not only manage reservations, but also provide FinTech-related functions and expand to the education and welfare fields to solve issues in a wide range of industries.
This strengthening of our management foundation will create an environment where we can directly leverage GMO-PG's knowledge of infrastructure of payments, security, and finance services. Furthermore, by pursuing synergies with the entire GMO-PG consolidation on a broader scale, we will accelerate the creation of new value and strengthen our competitiveness.

【Future Developments】
GMO-PG positions GMO Reserve Plus as one of the key players in payment field. By combining the strengths of both companies, we will achieve sustainable business growth on a consolidated basis.